NCT00170664View on ClinicalTrials.gov

Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

March 31, 2003

Study Completion Date

September 30, 2004

Conditions
Ovarian Cancer
Interventions
DRUG

Paclitaxel

DRUG

Carboplatin

Trial Locations (1)

13533

Charité Campus Virchow-Klinikum, Berlin

All Listed Sponsors
lead

North Eastern German Society of Gynaecological Oncology

OTHER

NCT00170664 - Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer | Biotech Hunter | Biotech Hunter